LexIA

Aviso: esto no es asesoría legal. LexIA solo organiza fuentes públicas y puede estar incompleto.

U.S. Code · Título 42

REQUIREMENT FOR CLINICAL TRIALS.

42 U.S.C. § 301

Office of the Law Revision Counsel · release 119-142

Texto oficial en GovInfo

Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.

Capítulo 6A

“(a)

In General.—

The Director of the National Institute on Aging shall provide for the conduct of clinical trials on the efficacy of the use of such promising therapeutic agents as have been or may be discovered and recommended for further scientific analysis by the National Institute on Aging and the Food and Drug Administration to treat individuals with Alzheimer’s disease, to retard the progression of symptoms of Alzheimer’s disease, or to improve the functioning of individuals with such disease.
“(b)

Rule of Construction.—

Nothing in this title shall be construed to affect adversely any research being conducted as of the date of the enactment of this Act [Nov. 29, 1987].